HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection and biological activities of carboxyethylpyrrole ethanolamine phospholipids (CEP-EPs).

Abstract
Oxidation of docosahexaenoate phospholipids produces 4-hydroxy-7-oxo-hept-5-eonyl phospholipids (HOHA-PLs) that react with protein lysyl ε-amino residues to generate 2-ω-carboxyethylpyrrole (CEP) derivatives, endogenous factors that induce angiogenesis in the retina and tumors. It seemed likely, but remained unproven, that HOHA-PLs react with ethanolamine phospholipids (EPs) in vivo to generate CEP-EPs. We now show that CEP-EPs are present in human blood at 4.6-fold higher levels in age-related macular degeneration plasma than in normal plasma. We also show that CEP-EPs are pro-angiogenic, inducing tube formation by human umbilical vein endothelial cells by activating Toll-like receptor 2. CEP-EP levels may be a useful biomarker for clinical assessment of AMD risk and CEP-associated tumor progression and a tool for monitoring the efficacy of therapeutic interventions.
AuthorsHua Wang, Junhong Guo, Xiaoxia Z West, Hemant K Bid, Liang Lu, Li Hong, Geeng-Fu Jang, Lei Zhang, John W Crabb, Clinical Genomic and Proteomic AMD Study Group, Mikhail Linetsky, Robert G Salomon
JournalChemical research in toxicology (Chem Res Toxicol) Vol. 27 Issue 12 Pg. 2015-22 (Dec 15 2014) ISSN: 1520-5010 [Electronic] United States
PMID25380349 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphatidylethanolamines
  • Phospholipids
  • phosphatidylethanolamine
Topics
  • Chromatography, Liquid
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Macular Degeneration (blood)
  • Magnetic Resonance Spectroscopy
  • Phosphatidylethanolamines (blood)
  • Phospholipids (blood, physiology)
  • Tandem Mass Spectrometry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: